DavidBZhenMD

PubMed

• Use of acupuncture with acupressure in addition to standard-of-care cryotherapy to decrease chemotherapy-associated neuropathy in patients with gastrointestinal malign...
  Stacey A Cohen, Susan Veleber, Jonathan Siman, Katherine A Guthrie, Kerry McMillen, Madilyn Heit, Sonia Wadhera, Jonathan Daniels, Kjell Hansen, Madeline Jacoby, Kathe...> ;Contemporary Clinical Trials. 2023 Aug 1
• 4 citations
  Devimistat in Combination with Gemcitabine and Cisplatin in Biliary Tract Cancer: Preclinical Evaluation and Phase Ib Multicenter Clinical Trial (BilT-04).
  Arathi Mohan, Kent A Griffith, Fulei Wuchu, David B Zhen, Chandan Kumar-Sinha, Oxana Crysler, David Hsiehchen, Thomas Enzler, Dominique Dippman, Valerie Gunchick, Abhi...> ;Clinical Cancer Research. 2023 Jul 5
• The GIANT trial (ECOG-ACRIN EA2186) methods paper: A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposoma...
  Efrat Dotan, Paul Catalano, Leon Lenchik, Robert Boutin, Xin Yao, Helga S Marques, Dina Ioffe, David B Zhen, Daneng Li, Lynne I Wagner, Melissa A Simon, Terence Z Wong...> ;Journal of Geriatric Oncology. 2023 Apr 1
• 4 citations
  The role of molecular testing in pancreatic cancer.
  David B Zhen, Rachael A Safyan, Eric Q Konick, Ryan Nguyen, Colin C Prichard, E Gabriela Chiorean> ;Therapeutic Advances in Gastroenterology. 2023 Jan 1
• 7 citations
  KRAS Mutation Variants and Co-occurring PI3K Pathway Alterations Impact Survival for Patients with Pancreatic Ductal Adenocarcinomas.
  Adam C Diehl, Lindsay M Hannan, David B Zhen, Andrew L Coveler, Gentry King, Stacey A Cohen, William P Harris, Veena Shankaran, Kit M Wong, Steven Green, Natasha Ng, V...> ;The Oncologist. 2022 Dec 9
• 5 citations
  Combination immunotherapy for pancreatic cancer: challenges and future considerations.
  Gustavo C L Gössling, David B Zhen, Venu G Pillarisetty, E Gabriela Chiorean> ;Expert Review of Clinical Immunology. 2022 Nov 1
• 19 citations
  A randomized phase 2 trial of nivolumab, gemcitabine, and cisplatin or nivolumab and ipilimumab in previously untreated advanced biliary cancer: BilT-01.
  Vaibhav Sahai, Kent A Griffith, Muhammad S Beg, Walid L Shaib, Devalingam Mahalingam, David B Zhen, Dustin A Deming, Mark M Zalupski> ;Cancer. 2022 Oct 1
• 1 citations
  DNA Damage Repair Defects and Survival Outcomes for Patients With Resected Pancreatic Ductal Adenocarcinoma.
  Amy Chang, Marc R. Radke, David Bing Zhen, Kelsey Baker, Andrew L. Coveler, Kit Man Wong, Venu G. Pillarisetty, Deepti M. Reddi, Mary W. Redman, Elizabeth M. Swisher, ...> ;Pancreas. 2021 May 1
• 19 citations
  Multiplex Enrichment and Detection of Rare KRAS Mutations in Liquid Biopsy Samples using Digital Droplet Pre-Amplification.
  Erica D. Pratt, Robert W. Cowan, Sara L. Manning, Edmund Qiao, Heather Cameron, Kara Schradle, Diane M. Simeone, David Bing Zhen> ;Analytical Chemistry. 2019 Jun 18
• 3 citations
  Irinotecan-associated dysarthria: A single institution case series with management implications in patients with gastrointestinal malignancies.
  David B Zhen, Rachel L McDevitt, Mark M. Zalupski, Vaibhav Sahai> ;Journal of Oncology Pharmacy Practice. 2019 Jun 1
• 5 citations
  Biomarker-driven and molecularly targeted therapies for pancreatic adenocarcinoma.
  David B. Zhen, Andrew Coveler, Silvia Zanon, Michele Reni, E. Gabriela Chiorean> ;Seminars in Oncology. 2018 Jun 1
• 24 citations
  A phase I trial of cabozantinib and gemcitabine in advanced pancreatic cancer.
  David Bing Zhen, Kent A. Griffith, Joshua M. Ruch, Kevin Camphausen, Jason E. Savage, Edward J. Kim, Vaibhav Sahai, Diane M. Simeone, Mark M. Zalupski> ;Investigational New Drugs. 2016 Jul 21
• 64 citations
  Metformin Use and Survival of Patients With Pancreatic Cancer: A Cautionary Lesson
  Roongruedee Chaiteerakij, Gloria M. Petersen, William R. Bamlet, Kari G. Chaffee, David B. Zhen, Patrick A. Burch, Emma R. Leof, Lewis R. Roberts, Ann L. Oberg> ;Journal of Clinical Oncology. 2016 Sep 27
• 19 citations
  Frequencies and geographic distributions of genetic mutations in transthyretin- and non-transthyretin-related familial amyloidosis
  D. B. Zhen, Paul L. Swiecicki, Steven R. Zeldenrust, Angela Dispenzieri, Michelle L. Mauermann, Morie A. Gertz> ;Clinical Genetics. 2015 Oct 1
• 199 citations
  BRCA1, BRCA2, PALB2, and CDKN2A mutations in familial pancreatic cancer: A PACGENE study
  David B. Zhen, Kari G. Rabe, Steven Gallinger, Sapna Syngal, Ann G. Schwartz, Michael Goggins, Ralph H. Hruban, Michele L. Cote, Robert R. McWilliams, Nicholas J. Robe...> ;Genetics in Medicine. 2015 Jul 2
• 69 citations
  Hereditary ATTR amyloidosis: a single-institution experience with 266 patients.
  Paul L. Swiecicki, David B. Zhen, Michelle L. Mauermann, Robert A. Kyle, Steven R. Zeldenrust, Martha Grogan, Angela Dispenzieri, Morie A. Gertz> ;Amyloid. 2015 Jul 1
• 5 citations
  Treatment of Cholesterol Embolization Syndrome in the Setting of an Acute Indication for Anticoagulation Therapy
  Hidong Kim, David B. Zhen, John C. Lieske, Robert D. McBane, Joseph P. Grande, Gurpreet S. Sandhu, Rowlens M. Melduni> ;Journal of Medical Cases. 2014 May 30
• Join now to see all